197. Xiao, L.; Leusink-Muis, T.; Kettelarij, N.; Van Ark, I.; Blijenberg, B.; Hesen, N.A.; Stahl, B.; Overbeek, S.A.; Garssen, J.; Folkerts, G.; et al. Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model. *Front. Immunol.* **2018**, *9*, 452. [CrossRef]

198. Payne, D.C.; Currier, R.L.; Staat, M.A.; Sahni, L.C.; Selvarangan, R.; Halasa, N.B.; Englund, J.A.; Weinberg, G.A.; Boom, J.A.; Szilagyi, P.G.; et al. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. *JAMA Pediatr.* **2015**, *169*, 1040. [CrossRef]

199. Greenberg, R.G.; Benjamin, D.K. Neonatal Candidiasis: Diagnosis, Prevention, and Treatment. *J. Infect.* **2014**, *69*, S19-S22. [CrossRef]

200. Gonia, S.; Tuepker, M.; Heisel, T.; Autran, C.; Bode, L.; Gale, C.A. Human Milk Oligosaccharides Inhibit *Candida albicans* Invasion of Human Premature Intestinal Epithelial Cells. *J. Nutr.* **2015**, *145*, 1992–1998. [CrossRef]

201. Kuntz, S.; Rudloff, S.; Kunz, C. Oligosaccharides from Human Milk Influence Growth-Related Characteristics of Intestinally Transformed and Non-Transformed Intestinal Cells. *Br. J. Nutr.* **2008**, *99*, 462–471. [CrossRef]

202. Salvo Romero, E.; Alonso Cotoner, C.; Pardo Camacho, C.; Casado Bedmar, M.; Vicario, M. The Intestinal Barrier Function and Its Involvement in Digestive Disease. *Rev. Esp. Enfermedades Dig.* **2015**, *108*, 686–696. [CrossRef]

203. Barker, N.; Ridgway, R.A.; Van Es, J.H.; Van De Wetering, M.; Begthel, H.; Van Den Born, M.; Danenberg, E.; Clarke, A.R.; Sansom, O.J.; Clevers, H. Crypt Stem Cells as the Cells-of-Origin of Intestinal Cancer. *Nature* **2009**, *457*, 608–611. [CrossRef]

204. Angeloni, S. Glycoprofiling with Micro-Arrays of Glycoconjugates and Lectins. *Glycobiology* **2004**, *15*, 31–41. [CrossRef] [PubMed]

205. Holscher, H.D.; Davis, S.R.; Tappenden, K.A. Human Milk Oligosaccharides Influence Maturation of Human Intestinal Caco-2Bbe and HT-29 Cell Lines. *J. Nutr.* **2014**, *144*, 586–591. [CrossRef] [PubMed]

206. Perdijk, O.; Van Baarlen, P.; Fernandez-Gutierrez, M.M.; Van Den Brink, E.; Schuren, F.H.J.; Brugman, S.; Savelkoul, H.F.J.; Kleerebezem, M.; Van Neerven, R.J.J. Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro. *Front. Immunol.* **2019**, *10*, 94. [CrossRef] [PubMed]

207. Chichlowski, M.; De Lartigue, G.; German, J.B.; Raybould, H.E.; Mills, D.A. Bifidobacteria Isolated From Infants and Cultured on Human Milk Oligosaccharides Affect Intestinal Epithelial Function. *J. Pediatr. Gastroenterol. Nutr.* **2012**, *55*, 321–327. [CrossRef]

208. Lewis, E.D.; Richard, C.; Larsen, B.M.; Field, C.J. The Importance of Human Milk for Immunity in Preterm Infants. *Clin. Perinatol.* **2017**, *44*, 23–47. [CrossRef]

209. Guo, S.; Gillingham, T.; Guo, Y.; Meng, D.; Zhu, W.; Walker, W.A.; Ganguli, K. Secretions of *Bifidobacterium infantis* and *Lactobacillus acidophilus* Protect Intestinal Epithelial Barrier Function. *J. Pediatr. Gastroenterol. Nutr.* **2017**, *64*, 404–412. [CrossRef]

210. Ten Bruggencate, S.J.; Bovee-Oudenhoven, I.M.; Feitsma, A.L.; Van Hoffen, E.; Schoterman, M.H. Functional Role and Mechanisms of Sialyllactose and Other Sialylated Milk Oligosaccharides. *Nutr. Rev.* **2014**, *72*, 377–389. [CrossRef]

211. Duncan, P.I.; Raymond, F.; Fuerholz, A.; Sprenger, N. Sialic Acid Utilisation and Synthesis in the Neonatal Rat Revisited. *PLoS ONE* **2009**, *4*, e8241. [CrossRef]

212. Jacobi, S.K.; Yatsunenko, T.; Li, D.; Dasgupta, S.; Yu, R.K.; Berg, B.M.; Chichlowski, M.; Odle, J. Dietary Isomers of Sialyllactose Increase Ganglioside Sialic Acid Concentrations in the Corpus Callosum and Cerebellum and Modulate the Colonic Microbiota of Formula-Fed Piglets. *J. Nutr.* **2016**, *146*, 200–208. [CrossRef]

213. Eker, F.; Bolat, E.; Pekdemir, B.; Duman, H.; Karav, S. Lactoferrin: Neuroprotection against Parkinson's Disease and Secondary Molecule for Potential Treatment. *Front. Aging Neurosci.* **2023**, *15*, 1204149. [CrossRef]

214. Wang, B. Sialic Acid Is an Essential Nutrient for Brain Development and Cognition. *Annu. Rev. Nutr.* **2009**, *29*, 177–222. [CrossRef] [PubMed]

215. Vázquez, E.; Barranco, A.; Ramírez, M.; Gruart, A.; Delgado-García, J.M.; Martínez-Lara, E.; Blanco, S.; Martín, M.J.; Castanys, E.; Buck, R.; et al. Effects of a Human Milk Oligosaccharide, 2'-Fucosyllactose, on Hippocampal Long-Term Potentiation and Learning Capabilities in Rodents. *J. Nutr. Biochem.* **2015**, *26*, 455–465. [CrossRef] [PubMed]

216. Bienenstock, J.; Buck, R.H.; Linke, H.; Forsythe, P.; Stanisz, A.M.; Kunze, W.A. Fucosylated but Not Sialylated Milk Oligosaccharides Diminish Colon Motor Contractions. *PLoS ONE* **2013**, *8*, e76236. [CrossRef] [PubMed]

217. Cho, S.; Zhu, Z.; Li, T.; Baluyot, K.; Howell, B.R.; Hazlett, H.C.; Elison, J.T.; Hauser, J.; Sprenger, N.; Wu, D.; et al. Human Milk 3'-Sialyllactose Is Positively Associated with Language Development during Infancy. *Am. J. Clin. Nutr.* **2021**, *114*, 588–597. [CrossRef]

218. Jorgensen, J.M.; Young, R.; Ashorn, P.; Ashorn, U.; Chaima, D.; Davis, J.C.; Goonatilleke, E.; Kumwenda, C.; Lebrilla, C.B.; Maleta, K.; et al. Associations of Human Milk Oligosaccharides and Bioactive Proteins with Infant Growth and Development among Malawian Mother-Infant Dyads. *Am. J. Clin. Nutr.* **2021**, *113*, 209–220. [CrossRef]

219. Oliveros, E.; Martín, M.J.; Torres-Espínola, F.J.; Segura-Moreno, M.T.; Ramírez, M.; Santos, A.; Rueda, R.; Escudero, M.; Catena, A.; Azaryah, H.; et al. Human Milk Levels of 2'-Fucosyllactose and 6'-Sialyllactose Are Positively Associated with Infant Neurodevelopment and Are Not Impacted by Maternal BMI or Diabetic Status. *J. Nutr. Food Sci.* **2021**, *4*, 100024.

220. Neu, J.; Walker, W.A. Necrotizing Enterocolitis. *N. Engl. J. Med.* **2011**, *364*, 255–264. [CrossRef]
221. Hintz, S.R.; Kendrick, D.E.; Stoll, B.J.; Vohr, B.R.; Fanaroff, A.A.; Donovan, E.F.; Poole, W.K.; Blakely, M.L.; Wright, L.; Higgins, R.; et al. Neurodevelopmental and Growth Outcomes of Extremely Low Birth Weight Infants After Necrotizing Enterocolitis. *Pediatrics* **2005**, *115*, 696–703. [CrossRef]

222. Wiciński, M.; Sawicka, E.; Gębalski, J.; Kubiak, K.; Malinowski, B. Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology. *Nutrients* **2020**, *12*, 266. [CrossRef]

223. Kuntz, S.; Kunz, C.; Rudloff, S. Oligosaccharides from Human Milk Induce Growth Arrest via G2/M by Influencing Growth-Related Cell Cycle Genes in Intestinal Epithelial Cells. *Br. J. Nutr.* **2009**, *101*, 1306. [CrossRef]

224. Wu, R.Y.; Li, B.; Koike, Y.; Määttänen, P.; Miyake, H.; Cadete, M.; Johnson-Henry, K.C.; Botts, S.R.; Lee, C.; Abrahamsson, T.R.; et al. Human Milk Oligosaccharides Increase Mucin Expression in Experimental Necrotizing Enterocolitis. *Mol. Nutr. Food Res.* **2019**, *63*, 1800658. [CrossRef] [PubMed]

225. Autran, C.A.; Kellman, B.P.; Kim, J.H.; Asztalos, E.; Blood, A.B.; Spence, E.C.H.; Patel, A.L.; Hou, J.; Lewis, N.E.; Bode, L. Human Milk Oligosaccharide Composition Predicts Risk of Necrotising Enterocolitis in Preterm Infants. *Gut* **2018**, *67*, 1064–1070. [CrossRef] [PubMed]

226. Van Niekerk, E.; Autran, C.A.; Nel, D.G.; Kirsten, G.F.; Blaauw, R.; Bode, L. Human Milk Oligosaccharides Differ between HIV-Infected and HIV-Uninfected Mothers and Are Related to Necrotizing Enterocolitis Incidence in Their Preterm Very-Low-Birth-Weight Infants. *J. Nutr.* **2014**, *144*, 1227–1233. [CrossRef] [PubMed]

227. Masi, A.C.; Embleton, N.D.; Lamb, C.A.; Young, G.; Granger, C.L.; Najera, J.; Smith, D.P.; Hoffman, K.L.; Petrosino, J.F.; Bode, L.; et al. Human Milk Oligosaccharide DSLNT and Gut Microbiome in Preterm Infants Predicts Necrotising Enterocolitis. *Gut* **2021**, *70*, 2273–2282. [CrossRef] [PubMed]

228. Wejryd, E.; Martí, M.; Marchini, G.; Werme, A.; Jonsson, B.; Landberg, E.; Abrahamsson, T.R. Low Diversity of Human Milk Oligosaccharides Is Associated with Necrotising Enterocolitis in Extremely Low Birth Weight Infants. *Nutrients* **2018**, *10*, 1556. [CrossRef]

229. Rousseaux, A.; Brosseau, C.; Le Gall, S.; Piloquet, H.; Barbarot, S.; Bodinier, M. Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents. *Front. Immunol.* **2021**, *12*, 680911. [CrossRef]

230. Nowak-Wegrzyn, A.; Czerkies, L.; Reyes, K.; Collins, B.; Heine, R.G. Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides. *Nutrients* **2019**, *11*, 1447. [CrossRef]

231. Liu, T.; Chen, P.; Munir, M.; Liu, L.; Li, C.; Li, A.; Fu, H. HMOs Modulate Immunoregulation and Gut Microbiota in a β-Lactoglobulin-Induced Allergic Mice Model. *J. Funct. Foods* **2020**, *70*, 103993. [CrossRef]

232. Castillo-Courtade, L.; Han, S.; Lee, S.; Mian, F.M.; Buck, R.; Forsythe, P. Attenuation of Food Allergy Symptoms Following Treatment with Human Milk Oligosaccharides in a Mouse Model. *Allergy* **2015**, *70*, 1091–1102. [CrossRef]

233. Lewandowski, A.J.; Lamata, P.; Francis, J.M.; Piechnik, S.K.; Ferreira, V.M.; Boardman, H.; Neubauer, S.; Singhal, A.; Leeson, P.; Lucas, A. Breast Milk Consumption in Preterm Neonates and Cardiac Shape in Adulthood. *Pediatrics* **2016**, *138*, e20160050. [CrossRef]

234. Varadharaj, S.; Helal, M.; Duska-McEwen, G.O.; Boslett, J.; Pereira, S.L.; Buck, R.H.; Ahmed, N.; Zweier, J.L. The Human Milk Oligosaccharide 3-Fucosyllactose Facilitates Preservation of Nitric Oxide-Induced Vasodilation in Aortic Vessels In Vitro. *FASEB J.* **2017**, *31*, lb808. [CrossRef]

235. EL-Khuffash, A.; Jain, A.; Lewandowski, A.J.; Levy, P.T. Preventing Disease in the 21st Century: Early Breast Milk Exposure and Later Cardiovascular Health in Premature Infants. *Pediatr. Res.* **2020**, *87*, 385–390. [CrossRef] [PubMed]

236. Bode, L.; Contractor, N.; Barile, D.; Pohl, N.; Prudden, A.R.; Boons, G.-J.; Jin, Y.-S.; Jennewein, S. Overcoming the Limited Availability of Human Milk Oligosaccharides: Challenges and Opportunities for Research and Application. *Nutr. Rev.* **2016**, *74*, 635–644. [CrossRef] [PubMed]

237. Karav, S.; Salcedo, J.; Frese, S.A.; Barile, D. Thoroughbred Mare's Milk Exhibits a Unique and Diverse Free Oligosaccharide Profile. *FEBS Open Bio* **2018**, *8*, 1219–1229. [CrossRef]

238. Zivkovic, A.M.; Barile, D. Bovine Milk as a Source of Functional Oligosaccharides for Improving Human Health. *Adv. Nutr.* **2011**, *2*, 284–289. [CrossRef]

239. Urashima, T.; Asakuma, S.; Leo, F.; Fukuda, K.; Messer, M.; Oftedal, O.T. The Predominance of Type I Oligosaccharides Is a Feature Specific to Human Breast Milk. *Adv. Nutr.* **2012**, *3*, 473S–482S. [CrossRef]

240. Goto, K.; Fukuda, K.; Senda, A.; Saito, T.; Kimura, K.; Glander, K.E.; Hinde, K.; Dittus, W.; Milligan, L.A.; Power, M.L.; et al. Chemical Characterization of Oligosaccharides in the Milk of Six Species of New and Old World Monkeys. *Glycoconj. J.* **2010**, *27*, 703–715. [CrossRef]

241. Gan, J.; Cao, C.; Stahl, B.; Zhao, X.; Yan, J. Advances and Challenges for Obtaining Human Milk Oligosaccharides: Extraction from Natural Sources and Synthesis by Intentional Design. *Trends Food Sci. Technol.* **2023**, *141*, 104203. [CrossRef]

242. Thurl, S.; Offermanns, J.; Müller-Werner, B.; Sawatzki, G. Determination of Neutral Oligosaccharide Fractions from Human Milk by Gel Permeation Chromatography. *J. Chromatogr. B. Biomed. Sci. Appl.* **1991**, *568*, 291–300. [CrossRef]
243. Hair, A.B.; Bergner, E.M.; Lee, M.L.; Moreira, A.G.; Hawthorne, K.M.; Rechtman, D.J.; Abrams, S.A.; Blanco, C.L. Premature Infants 750–1250 g Birth Weight Supplemented with a Novel Human Milk-Derived Cream Are Discharged Sooner. *Breastfeed. Med.* **2016**, *11*, 133–137. [CrossRef]

244. Barile, D.; Tao, N.; Lebrilla, C.B.; Coisson, J.-D.; Arlorio, M.; German, J.B. Permeate from Cheese Whey Ultrafiltration Is a Source of Milk Oligosaccharides. *Int. Dairy J.* **2009**, *19*, 524–530. [CrossRef] [PubMed]

245. Charbonneau, M.R.; O'Donnell, D.; Blanton, L.V.; Totten, S.M.; Davis, J.C.C.; Barratt, M.J.; Cheng, J.; Guruge, J.; Talcott, M.; Bain, J.R.; et al. Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition. *Cell* **2016**, *164*, 859–871. [CrossRef] [PubMed]

246. Cowardin, C.A.; Ahern, P.P.; Kung, V.L.; Hibberd, M.C.; Cheng, J.; Guruge, J.L.; Sundaresan, V.; Head, R.D.; Barile, D.; Mills, D.A.; et al. Mechanisms by Which Sialylated Milk Oligosaccharides Impact Bone Biology in a Gnotobiotic Mouse Model of Infant Undernutrition. *Proc. Natl. Acad. Sci. USA* **2019**, *116*, 11988–11996. [CrossRef] [PubMed]

247. Arslan, A.; Kaplan, M.; Duman, H.; Bayraktar, A.; Ertürk, M.; Henrick, B.M.; Frese, S.A.; Karav, S. Bovine Colostrum and Its Potential for Human Health and Nutrition. *Front. Nutr.* **2021**, *8*, 651721. [CrossRef]

248. Arslan, A.; Duman, H.; Kaplan, M.; Uzkuç, H.; Bayraktar, A.; Ertürk, M.; Alkan, M.; Frese, S.A.; Duar, R.M.; Henrick, B.M.; et al. Determining Total Protein and Bioactive Protein Concentrations in Bovine Colostrum. *J. Vis. Exp.* **2021**, *178*, 63001. [CrossRef]

249. Yalçınçaş, Y.M.; Duman, H.; Rocha, J.M.; Bartkiene, E.; Karav, S.; Ozogul, F. Role of Bovine Colostrum against Various Diseases. *Food Biosci.* **2024**, *61*, 104818. [CrossRef]

250. Duman, H.; Karav, S. Bovine Colostrum and Its Potential Contributions for Treatment and Prevention of COVID-19. *Front. Immunol.* **2023**, *14*, 1214514. [CrossRef]

251. Kaplan, M.; Arslan, A.; Duman, H.; Karyelioğlu, M.; Baydemir, B.; Günar, B.B.; Alkan, M.; Bayraktar, A.; Tosun, H.İ.; Ertürk, M.; et al. Production of Bovine Colostrum for Human Consumption to Improve Health. *Front. Pharmacol.* **2022**, *12*, 796824. [CrossRef]

252. Coşkun, N.; Sarıtaş, S.; Jaouhari, Y.; Bordiga, M.; Karav, S. The Impact of Freeze Drying on Bioactivity and Physical Properties of Food Products. *Appl. Sci.* **2024**, *14*, 9183. [CrossRef]

253. Barnett, A.; Roy, N.; McNabb, W.; Cookson, A. Effect of a Semi-Purified Oligosaccharide-Enriched Fraction from Caprine Milk on Barrier Integrity and Mucin Production of Co-Culture Models of the Small and Large Intestinal Epithelium. *Nutrients* **2016**, *8*, 267. [CrossRef]

254. Martín-Ortiz, A.; Barile, D.; Salcedo, J.; Moreno, F.J.; Clemente, A.; Ruiz-Matute, A.I.; Sanz, M.L. Changes in Caprine Milk Oligosaccharides at Different Lactation Stages Analyzed by High Performance Liquid Chromatography Coupled to Mass Spectrometry. *J. Agric. Food Chem.* **2017**, *65*, 3523–3531. [CrossRef] [PubMed]

255. Wang, Y.; Yu, J. Membrane Separation Processes for Enrichment of Bovine and Caprine Milk Oligosaccharides from Dairy Byproducts. *Compr. Rev. Food Sci. Food Saf.* **2021**, *20*, 3667–3689. [CrossRef] [PubMed]

256. Walsh, C.; Lane, J.A.; Van Sinderen, D.; Hickey, R.M. From Lab Bench to Formulated Ingredient: Characterization, Production, and Commercialization of Human Milk Oligosaccharides. *J. Funct. Foods* **2020**, *72*, 104052. [CrossRef]

257. Schmidt, D.; Thiem, J. Chemical Synthesis Using Enzymatically Generated Building Units for Construction of the Human Milk Pentasaccharides Sialyllacto-*N*-Tetraose and Sialyllacto-*N*-Neotetraose Epimer. *Beilstein J. Org. Chem.* **2010**, *6*, 18. [CrossRef]

258. Agoston, K.; Hederos, M.J.; Bajza, I.; Dekany, G. Kilogram Scale Chemical Synthesis of 2'-Fucosyllactose. *Carbohydr. Res.* **2019**, *476*, 71–77. [CrossRef]

259. Cohen, J.L.; Karav, S.; Barile, D.; De Moura Bell, J.M.L.N. Immobilization of an Endo-β-*N*-Acetylglucosaminidase for the Release of Bioactive *N*-Glycans. *Catalysts* **2018**, *8*, 278. [CrossRef]

260. Frohnmeyer, H.; Elling, L. Enzyme Cascades for the Synthesis of Nucleotide Sugars: Updates to Recent Production Strategies. *Carbohydr. Res.* **2023**, *523*, 108727. [CrossRef]

261. Franceus, J.; Lormans, J.; Desmet, T. Building Mutational Bridges between Carbohydrate-Active Enzymes. *Curr. Opin. Biotechnol.* **2022**, *78*, 102804. [CrossRef]

262. Teze, D.; Zhao, J.; Wiemann, M.; Kazi, Z.G.A.; Lupo, R.; Zeuner, B.; Vuillemin, M.; Rønne, M.E.; Carlström, G.; Duus, J.Ø.; et al. Rational Enzyme Design without Structural Knowledge: A Sequence-Based Approach for Efficient Generation of Transglycosylases. *Chem.-Eur. J.* **2021**, *27*, 10323–10334. [CrossRef]

263. Karav, S.; Cohen, J.L.; Barile, D.; De Moura Bell, J.M.L.N. Recent Advances in Immobilization Strategies for Glycosidases. *Biotechnol. Prog.* **2017**, *33*, 104–112. [CrossRef]

264. Guo, Y.; Jers, C.; Meyer, A.S.; Arnous, A.; Li, H.; Kirpekar, F.; Mikkelsen, J.D. A Pasteurella Multocida Sialyltransferase Displaying Dual Trans-Sialidase Activities for Production of 3'-Sialyl and 6'-Sialyl Glycans. *J. Biotechnol.* **2014**, *170*, 60–67. [CrossRef] [PubMed]

265. Schmölzer, K.; Czabany, T.; Luley-Goedl, C.; Pavkov-Keller, T.; Ribitsch, D.; Schwab, H.; Gruber, K.; Weber, H.; Nidetzky, B. Complete Switch from α-2,3- to α-2,6-Regioselectivity in Pasteurella Dagmatis β-D-Galactoside Sialyltransferase by Active-Site Redesign. *Chem. Commun.* **2015**, *51*, 3083–3086. [CrossRef]
266. Perna, V.N.; Dehlholm, C.; Meyer, A.S. Enzymatic Production of 3'-Sialyllactose in Milk. *Enzyme Microb. Technol.* **2021**, *148*, 109829.
[CrossRef] [PubMed]

267. Zeuner, B.; Vuillemin, M.; Holck, J.; Muschiol, J.; Meyer, A.S. Loop Engineering of an α-1,3/4-1-Fucosidase for Improved Synthesis of Human Milk Oligosaccharides. *Enzyme Microb. Technol.* **2018**, *115*, 37–44. [CrossRef] [PubMed]

268. Xiao, Z.; Guo, Y.; Liu, Y.; Li, L.; Zhang, Q.; Wen, L.; Wang, X.; Kondengaden, S.M.; Wu, Z.; Zhou, J.; et al. Chemoenzymatic Synthesis of a Library of Human Milk Oligosaccharides. *J. Org. Chem.* **2016**, *81*, 5851–5865. [CrossRef]

269. Guzmán-Rodríguez, F.; Alatorre-Santamaría, S.; Cruz-Guerrero, A. Human Milk Oligosaccharides (HMOS). In *Handbook of Food Bioactive Ingredients*; Jafari, S.M., Rashidinejad, A., Simal-Gandara, J., Eds.; Springer International Publishing: Cham, Switzerland, 2022; pp. 1–29. ISBN 978-3-030-81404-5.

270. Chen, C.; Zhang, Y.; Xue, M.; Liu, X.; Li, Y.; Chen, X.; Wang, P.G.; Wang, F.; Cao, H. Sequential One-Pot Multienzyme (OPME) Synthesis of Lacto-N-Neotetraose and Its Sialyl and Fucosyl Derivatives. *Chem. Commun.* **2015**, *51*, 7689–7692. [CrossRef]

271. Prudden, A.R.; Liu, L.; Capicciotti, C.J.; Wolfert, M.A.; Wang, S.; Gao, Z.; Meng, L.; Moremen, K.W.; Boons, G.-J. Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides. *Proc. Natl. Acad. Sci. USA* **2017**, *114*, 6954–6959. [CrossRef]

272. Rugbjerg, P.; Sommer, M.O.A. Overcoming Genetic Heterogeneity in Industrial Fermentations. *Nat. Biotechnol.* **2019**, *37*, 869–876.
[CrossRef]

273. Lee, S.Y.; Kim, H.U. Systems Strategies for Developing Industrial Microbial Strains. *Nat. Biotechnol.* **2015**, *33*, 1061–1072. [CrossRef]

274. Baumgärtner, F.; Seitz, L.; Sprenger, G.A.; Albermann, C. Construction of *Escherichia coli* Strains with Chromosomally Integrated Expression Cassettes for the Synthesis of 2'-Fucosyllactose. *Microb. Cell Factories* **2013**, *12*, 40. [CrossRef]

275. Lee, W.-H.; Pathanibul, P.; Quarterman, J.; Jo, J.-H.; Han, N.S.; Miller, M.J.; Jin, Y.-S.; Seo, J.-H. Whole Cell Biosynthesis of a Functional Oligosaccharide, 2'-Fucosyllactose, Using Engineered *Escherichia coli*. *Microb. Cell Factories* **2012**, *11*, 48. [CrossRef] [PubMed]

276. Deng, J.; Gu, L.; Chen, T.; Huang, H.; Yin, X.; Lv, X.; Liu, Y.; Li, N.; Liu, Z.; Li, J.; et al. Engineering the Substrate Transport and Cofactor Regeneration Systems for Enhancing 2'-Fucosyllactose Synthesis in *Bacillus Subtilis*. *ACS Synth. Biol.* **2019**, *8*, 2418–2427.
[CrossRef] [PubMed]

277. Hollands, K.; Baron, C.M.; Gibson, K.J.; Kelly, K.J.; Krasley, E.A.; Laffend, L.A.; Lauchli, R.M.; Maggio-Hall, L.A.; Nelson, M.J.; Prasad, J.C.; et al. Engineering Two Species of Yeast as Cell Factories for 2'-Fucosyllactose. *Metab. Eng.* **2019**, *52*, 232–242.
[CrossRef] [PubMed]

278. Fierfort, N.; Samain, E. Genetic Engineering of *Escherichia coli* for the Economical Production of Sialylated Oligosaccharides. *J. Biotechnol.* **2008**, *134*, 261–265. [CrossRef]

279. Drouillard, S.; Mine, T.; Kajiwara, H.; Yamamoto, T.; Samain, E. Efficient Synthesis of 6'-Sialyllactose, 6,6'-Disialyllactose, and 6'-KDO-Lactose by Metabolically Engineered *E. coli* Expressing a Multifunctional Sialyltransferase from the *Photobacterium* sp. JT-ISH-224. *Carbohydr. Res.* **2010**, *345*, 1394–1399. [CrossRef]

280. Wang, Y.; Zhou, X.; Gong, P.; Chen, Y.; Feng, Z.; Liu, P.; Zhang, P.; Wang, X.; Zhang, L.; Song, L. Comparative Major Oligosaccharides and Lactose between Chinese Human and Animal Milk. *Int. Dairy J.* **2020**, *108*, 104727. [CrossRef]

281. Urashima, T.; Taufik, E.; Fukuda, K.; Asakuma, S. Recent Advances in Studies on Milk Oligosaccharides of Cows and Other Domestic Farm Animals. *Biosci. Biotechnol. Biochem.* **2013**, *77*, 455–466. [CrossRef]

282. Nakamura, T.; Kawase, H.; Kimura, K.; Watanabe, Y.; Ohtani, M.; Arai, I.; Urashima, T. Concentrations of Sialyloligosaccharides in Bovine Colostrum and Milk during the Prepartum and Early Lactation. *J. Dairy Sci.* **2003**, *86*, 1315–1320. [CrossRef]

283. Albrecht, S.; Lane, J.A.; Mariño, K.; Al Busadah, K.A.; Carrington, S.D.; Hickey, R.M.; Rudd, P.M. A Comparative Study of Free Oligosaccharides in the Milk of Domestic Animals. *Br. J. Nutr.* **2014**, *111*, 1313–1328. [CrossRef]

284. Shi, Y.; Han, B.; Zhang, L.; Zhou, P. Comprehensive Identification and Absolute Quantification of Milk Oligosaccharides in Different Species. *J. Agric. Food Chem.* **2021**, *69*, 15585–15597. [CrossRef]

285. Chatziioannou, A.C.; Benjamins, E.; Pellis, L.; Haandrikman, A.; Dijkhuizen, L.; Van Leeuwen, S.S. Extraction and Quantitative Analysis of Goat Milk Oligosaccharides: Composition, Variation, Associations, and 2'-FL Variability. *J. Agric. Food Chem.* **2021**, *69*, 7851–7862. [CrossRef]

286. Zhang, L.; Lin, Q.; Zhang, J.; Shi, Y.; Pan, L.; Hou, Y.; Peng, X.; Li, W.; Wang, J.; Zhou, P. Qualitative and Quantitative Changes of Oligosaccharides in Human and Animal Milk over Lactation. *J. Agric. Food Chem.* **2023**, *71*, 15553–15568. [CrossRef]

287. Van Leeuwen, S.S.; Te Poele, E.M.; Chatziioannou, A.C.; Benjamins, E.; Haandrikman, A.; Dijkhuizen, L. Goat Milk Oligosaccharides: Their Diversity, Quantity, and Functional Properties in Comparison to Human Milk Oligosaccharides. *J. Agric. Food Chem.* **2020**, *68*, 13469–13485. [CrossRef] [PubMed]

288. Claps, S.; Di Napoli, M.A.; Caputo, A.R.; Rufrano, D.; Sepe, L.; Di Trana, A. Factor Affecting the 3' Sialyllactose, 6' Sialyllactose and Disialyllactose Content in Caprine Colostrum and Milk: Breed and Parity. *Small Rumin. Res.* **2016**, *134*, 8–13. [CrossRef]

289. Claps, S.; Di Napoli, M.A.; Sepe, L.; Caputo, A.R.; Rufrano, D.; Di Trana, A.; Annicchiarico, G.; Fedele, V. Sialyloligosaccharides Content in Colostrum and Milk of Two Goat Breeds. *Small Rumin. Res.* **2014**, *121*, 116–119. [CrossRef]
290. Nakamura, T.; Amikawa, S.; Harada, T.; Saito, T.; Arai, I.; Urashima, T. Occurrence of an Unusual Phosphorylated N-Acetyllactosamine in Horse Colostrum. *Biochim. Biophys. Acta BBA-Gen. Subj.* **2001**, *1525*, 13-18. [CrossRef]

291. Difilippo, E.; Willems, H.A.M.; Vendrig, J.C.; Fink-Gremmels, J.; Gruppen, H.; Schols, H.A. Comparison of Milk Oligosaccharides Pattern in Colostrum of Different Horse Breeds. *J. Agric. Food Chem.* **2015**, *63*, 4805-4814. [CrossRef]

292. Tao, N.; Wu, S.; Kim, J.; An, H.J.; Hinde, K.; Power, M.L.; Gagneux, P.; German, J.B.; Lebrilla, C.B. Evolutionary Glycomics: Characterization of Milk Oligosaccharides in Primates. *J. Proteome Res.* **2011**, *10*, 1548-1557. [CrossRef]

293. Zuurveld, M.; Van Witzenburg, N.P.; Garssen, J.; Folkerts, G.; Stahl, B.; Van'T Land, B.; Willemsen, L.E.M. Immunomodulation by Human Milk Oligosaccharides: The Potential Role in Prevention of Allergic Diseases. *Front. Immunol.* **2020**, *11*, 801. [CrossRef]

294. Zeuner, B.; Teze, D.; Muschiol, J.; Meyer, A.S. Synthesis of Human Milk Oligosaccharides: Protein Engineering Strategies for Improved Enzymatic Transglycosylation. *Molecules* **2019**, *24*, 2033. [CrossRef]

295. Dinleyici, M.; Barbieur, J.; Dinleyici, E.C.; Vandenplas, Y. Functional Effects of Human Milk Oligosaccharides (HMOs). *Gut Microbes* **2023**, *15*, 2186115. [CrossRef] [PubMed]

296. Bührer, C.; Ensenauer, R.; Jochum, F.; Kalhoff, H.; Koletzko, B.; Lawrenz, B.; Mihatsch, W.; Posovszky, C.; Rudloff, S. Infant Formulas with Synthetic Oligosaccharides and Respective Marketing Practices: Position Statement of the German Society for Child and Adolescent Medicine e.V. (DGKJ), Commission for Nutrition. *Mol. Cell. Pediatr.* **2022**, *9*, 14. [CrossRef] [PubMed]

297. Puccio, G.; Alliet, P.; Cajozzo, C.; Janssens, E.; Corsello, G.; Sprenger, N.; Wernimont, S.; Egli, D.; Gosoniu, L.; Steenhout, P. Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. *J. Pediatr. Gastroenterol. Nutr.* **2017**, *64*, 624-631. [CrossRef] [PubMed]

298. Goehring, K.C.; Marriage, B.J.; Oliver, J.S.; Wilder, J.A.; Barrett, E.G.; Buck, R.H. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. *J. Nutr.* **2016**, *146*, 2559-2566. [CrossRef]

299. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Safety of 2'-O-fucosyllactose as a Novel Food Ingredient Pursuant to Regulation (EC) No 258/97. *EFSA J. Nutr.* **2015**, *13*, 4184. [CrossRef]

300. Kajzer, J.; Oliver, J.; Marriage, B. Gastrointestinal Tolerance of Formula Supplemented with Oligosaccharides. *FASEB J.* **2016**, *30*, 671.4. [CrossRef]

301. Berger, B.; Porta, N.; Foata, F.; Grathwohl, D.; Delley, M.; Moine, D.; Charpagne, A.; Siegwald, L.; Descombes, P.; Alliet, P.; et al. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics. *mBio* **2020**, *11*, e03196-19. [CrossRef]

302. Vandenplas, Y.; De Halleux, V.; Arciszewska, M.; Lach, P.; Pokhylko, V.; Klymenko, V.; Schoen, S.; Abrahamse-Berkeveld, M.; Mulder, K.; Porcel Rubio, R.; et al. A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial. *Nutrients* **2020**, *12*, 3560. [CrossRef]

303. Parschat, K.; Melsaether, C.; Jäpelt, K.R.; Jennewein, S. Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth. *Nutrients* **2021**, *13*, 2871. [CrossRef]

304. Lasekan, J.; Choe, Y.; Dvoretskiy, S.; Devitt, A.; Zhang, S.; Mackey, A.; Wulf, K.; Buck, R.; Steele, C.; Johnson, M.; et al. Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial. *Nutrients* **2022**, *14*, 2625. [CrossRef]

305. Wallingford, J.C.; Neve Myers, P.; Barber, C.M. Effects of Addition of 2-Fucosyllactose to Infant Formula on Growth and Specific Pathways of Utilization by *Bifidobacterium* in Healthy Term Infants. *Front. Nutr.* **2022**, *9*, 961526. [CrossRef] [PubMed]

306. Ramirez-Farias, C.; Baggs, G.E.; Marriage, B.J. Growth, Tolerance, and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula with Added 2'-FL Fucosyllactose (2'-FL) Human Milk Oligosaccharide. *Nutrients* **2021**, *13*, 186. [CrossRef] [PubMed]

307. Vandenplas, Y.; Żołnowska, M.; Berni Canani, R.; Ludman, S.; Tengelyi, Z.; Moreno-Álvarez, A.; Goh, A.E.N.; Gosoniu, M.L.; Kirwan, B.-A.; Tadi, M.; et al. Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow's Milk Protein Allergy: A Randomized, Multi-Center Trial. *Nutrients* **2022**, *14*, 530. [CrossRef] [PubMed]

308. Gold, M.S.; Quinn, P.J.; Campbell, D.E.; Peake, J.; Smart, J.; Robinson, M.; O'Sullivan, M.; Vogt, J.K.; Pedersen, H.K.; Liu, X.; et al. Effects of an Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety, and Gut Microbiome in Infants with Cow's Milk Protein Allergy. *Nutrients* **2022**, *14*, 2297. [CrossRef]

309. Meli, F.; Puccio, G.; Cajozzo, C.; Ricottone, G.L.; Pecquet, S.; Sprenger, N.; Steenhout, P. Growth and Safety Evaluation of Infant Formulae Containing Oligosaccharides Derived from Bovine Milk: A Randomized, Double-Blind, Noninferiority Trial. *BMC Pediatr.* **2014**, *14*, 306. [CrossRef]

310. Martín-Sosa, S.; Martín, M.-J.; García-Pardo, L.-A.; Hueso, P. Sialyloligosaccharides in Human and Bovine Milk and in Infant Formulas: Variations with the Progression of Lactation. *J. Dairy Sci.* **2003**, *86*, 52-59. [CrossRef]
311. Marriage, B.J.; Buck, R.H.; Goehring, K.C.; Oliver, J.S.; Williams, J.A. Infants Fed a Lower Calorie Formula With 2' FL Show Growth and 2' FL Uptake Like Breast-Fed Infants. *J. Pediatr. Gastroenterol. Nutr.* **2015**, *61*, 649–658. [CrossRef]

312. Storm, H.M.; Shepard, J.; Czerkies, L.M.; Kineman, B.; Cohen, S.S.; Reichert, H.; Carvalho, R. 2'-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With *Bifidobacterium lactis*: A Randomized Controlled Trial. *Glob. Pediatr. Health* **2019**, *6*, 2333794X1983399. [CrossRef]

313. Román, E.; Moreno Villares, J.M.; Domínguez Ortega, F.; Carmona Martínez, A.; Picó Sirvent, L.; Santana Sandoval, L.; Casas Rivero, J.; Alshweki, A.; Cercamondi, C.; Dahbane, S.; et al. Real-World Study in Infants Fed an Infant Formula with Two Human Milk Oligosaccharides. *Nutr. Hosp.* **2020**, *37*, 698–706. [CrossRef]

314. Leung, T.F.; Ulfman, L.H.; Chong, M.K.C.; Hon, K.L.; Khouw, I.M.S.L.; Chan, P.K.S.; Delsing, D.J.; Kortman, G.A.M.; Bovee-Oudenhoven, I.M.J. A Randomized Controlled Trial of Different Young Child Formulas on Upper Respiratory and Gastrointestinal Tract Infections in Chinese Toddlers. *Pediatr. Allergy Immunol.* **2020**, *31*, 745–754. [CrossRef]

315. Hascoët, J.-M.; Chevallier, M.; Gire, C.; Brat, R.; Rozé, J.-C.; Norbert, K.; Chen, Y.; Hartweg, M.; Billeaud, C. Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-Term Infants. *Front. Pediatr.* **2022**, *10*, 858380. [CrossRef]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.